Skip to main content
Erschienen in: Clinical and Experimental Nephrology 3/2012

01.06.2012 | Original Article

Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in incident hemodialysis patients

verfasst von: Harin Rhee, Sang Heon Song, Ihm Soo Kwak, Soo Bong Lee, Dong Won Lee, Eun Young Seong, Il Young Kim

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Recent observational studies have found that low intact parathyroid hormone (iPTH) is related with mortality in hemodialysis patients and these findings may be considered to be the result of accelerated cardiovascular calcifications in adynamic bone disease. This study was aimed to determine the relationship between persistently low iPTH and aortic arch calcification (AAC) in incident hemodialysis patients.

Methods

From January 2004 to December 2008, a total of 94 incident hemodialysis patients were enrolled in this study. They were divided into three groups according to the changing patterns of iPTH during the first year of hemodialysis. ACC was scored on posterior–anterior plain chest X-rays using a specific scale at the initiation of dialysis and followed till May 2011.

Results

The median follow-up periods were 46.9 months. The prevalence of baseline AAC and its progression were the highest in the persistently low iPTH group. Also, all-cause mortality was the highest in this group. Age, baseline calcification score and persistently low iPTH independently contributed to the progression of calcification by multivariate logistic regression analyses (HR 1.083, 95% CI 1.023–1.147, P = 0.006; HR 3.320, 95% CI 1.023–10.789, P = 0.046; HR 5.207, 95% CI 1.027–26.412, P = 0.046, respectively). Also, mortality was relatively higher in calcification progressor compared to non-progressor (39.3, 18.2%, P = 0.030).

Conclusion

Persistently low iPTH was an independent risk factor for both AAC and mortality in incident hemodialysis patients.
Literatur
1.
Zurück zum Zitat Cannata-Andia JB, Rodriguez-Garcia M, Carrillo-Lopez N, Naves-Diaz M, Diaz-Lopez B. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol. 2006;17:267–73.CrossRef Cannata-Andia JB, Rodriguez-Garcia M, Carrillo-Lopez N, Naves-Diaz M, Diaz-Lopez B. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol. 2006;17:267–73.CrossRef
2.
Zurück zum Zitat London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transpl. 2003;18:1731–40.CrossRef London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transpl. 2003;18:1731–40.CrossRef
3.
Zurück zum Zitat El-Abbadi M, Giachelli CM. Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench. Curr Opin Nephrol Hypertens. 2005;14:519–24.PubMedCrossRef El-Abbadi M, Giachelli CM. Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench. Curr Opin Nephrol Hypertens. 2005;14:519–24.PubMedCrossRef
4.
Zurück zum Zitat Ohya M, Otani H, Kimura K, Saika Y, Fujii R, Yukawa S, et al. Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients. Clin Exp Nephrol. 2011. Epub ahead of print. Ohya M, Otani H, Kimura K, Saika Y, Fujii R, Yukawa S, et al. Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients. Clin Exp Nephrol. 2011. Epub ahead of print.
5.
Zurück zum Zitat Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol. 2011;6:913–21.PubMedCrossRef Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol. 2011;6:913–21.PubMedCrossRef
6.
Zurück zum Zitat Tamei N, Ogawa T, Ishida H, Ando Y, Nitta K. Serum fibroblast growth factor-23 levels and progression of aortic arch calcification in non-diabetic patients on chronic hemodialysis. J Atheroscler Thromb. 2011;18:217–23.PubMedCrossRef Tamei N, Ogawa T, Ishida H, Ando Y, Nitta K. Serum fibroblast growth factor-23 levels and progression of aortic arch calcification in non-diabetic patients on chronic hemodialysis. J Atheroscler Thromb. 2011;18:217–23.PubMedCrossRef
7.
Zurück zum Zitat Martin KJ, Gonzalez EA. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat? Clin J Am Soc Nephrol. 2011;6:440–6.PubMedCrossRef Martin KJ, Gonzalez EA. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat? Clin J Am Soc Nephrol. 2011;6:440–6.PubMedCrossRef
8.
Zurück zum Zitat Ogata H, Koiwa F, Kinugasa E, Akizawa T. CKD-MBD: impact on management of kidney disease. Clin Exp Nephrol. 2007;11(4):261–8.PubMedCrossRef Ogata H, Koiwa F, Kinugasa E, Akizawa T. CKD-MBD: impact on management of kidney disease. Clin Exp Nephrol. 2007;11(4):261–8.PubMedCrossRef
9.
Zurück zum Zitat Cozzolino M, Brandenburg V. Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the “U”. Clin Nephrol. 2009;71:593–601.PubMed Cozzolino M, Brandenburg V. Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the “U”. Clin Nephrol. 2009;71:593–601.PubMed
10.
Zurück zum Zitat Avram MM, Mittman N, Myint MM, Fein P. Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis. 2011;38:1351–7.CrossRef Avram MM, Mittman N, Myint MM, Fein P. Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation. Am J Kidney Dis. 2011;38:1351–7.CrossRef
11.
Zurück zum Zitat Guh JY, Chen HC, Chuang HY, Huang SC, Chien LC, Lai YH. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. Am J Kidney Dis. 2002;39:1245–54.PubMedCrossRef Guh JY, Chen HC, Chuang HY, Huang SC, Chien LC, Lai YH. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. Am J Kidney Dis. 2002;39:1245–54.PubMedCrossRef
12.
Zurück zum Zitat Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol. 2004;15:770–9.PubMedCrossRef Stevens LA, Djurdjev O, Cardew S, Cameron EC, Levin A. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol. 2004;15:770–9.PubMedCrossRef
13.
Zurück zum Zitat Bieglmayer C, Prager G, Niederle B. Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy. Clin Chem. 2002;48:1731–8.PubMed Bieglmayer C, Prager G, Niederle B. Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy. Clin Chem. 2002;48:1731–8.PubMed
14.
Zurück zum Zitat The guideline committee of the Japanese Society for DialysisTherapy. Guidelines for the management of secondary hyperparathyroidism in chronic dialysis patients. J Jpn Soc Dial Ther. 2006;36:1435–55. The guideline committee of the Japanese Society for DialysisTherapy. Guidelines for the management of secondary hyperparathyroidism in chronic dialysis patients. J Jpn Soc Dial Ther. 2006;36:1435–55.
15.
Zurück zum Zitat Ogawa T, Ishida H, Matsuda N, Fujiu A, Matsuda A, Ito K, et al. Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients. Hemodial Int. 2009;13:301–6.PubMedCrossRef Ogawa T, Ishida H, Matsuda N, Fujiu A, Matsuda A, Ito K, et al. Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients. Hemodial Int. 2009;13:301–6.PubMedCrossRef
16.
Zurück zum Zitat National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1–201. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1–201.
17.
Zurück zum Zitat National Kidney Foundation. K/DOQI clinical practice guidelines and clinical practice recommendations for 2006 updates. Am J Kidney Dis. 2006;48 Suppl 1:S1–322. National Kidney Foundation. K/DOQI clinical practice guidelines and clinical practice recommendations for 2006 updates. Am J Kidney Dis. 2006;48 Suppl 1:S1–322.
18.
Zurück zum Zitat Iribarren C, Sidney S, Sternfeld B, Browner WS. Calcification of the aortic arch: risk f actors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA. 2000;283:2810–5.PubMedCrossRef Iribarren C, Sidney S, Sternfeld B, Browner WS. Calcification of the aortic arch: risk f actors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA. 2000;283:2810–5.PubMedCrossRef
19.
Zurück zum Zitat Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC. A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transpl. 1999;14:1732–8. Kalantar-Zadeh K, Kleiner M, Dunne E, Lee GH, Luft FC. A modified quantitative subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transpl. 1999;14:1732–8.
20.
Zurück zum Zitat Feroze U, Molnar MZ, Dukkipati R, Kovesdy CP, Kalantar-Zadeh K. Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients. J Ren Nutr. 2011;21:100–4.PubMedCrossRef Feroze U, Molnar MZ, Dukkipati R, Kovesdy CP, Kalantar-Zadeh K. Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients. J Ren Nutr. 2011;21:100–4.PubMedCrossRef
21.
Zurück zum Zitat Lafage-Proust MH, Combe C, Barthe N, Aparicio M. Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction. J Clin Endocrinol Metab. 1999;84:512–9. Lafage-Proust MH, Combe C, Barthe N, Aparicio M. Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction. J Clin Endocrinol Metab. 1999;84:512–9.
22.
Zurück zum Zitat Galassi A, Spiegel DM, Bellasi A, Block GA, Raggi P. Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders. Nephrol Dial Transpl. 2006;21:3215–22.CrossRef Galassi A, Spiegel DM, Bellasi A, Block GA, Raggi P. Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders. Nephrol Dial Transpl. 2006;21:3215–22.CrossRef
23.
Zurück zum Zitat Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int. 1994;46:855–61.PubMedCrossRef Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, et al. Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int. 1994;46:855–61.PubMedCrossRef
24.
Zurück zum Zitat Cannata-Andia JB. Adynamic bone and chronic renal failure: an overview. Am J Med Sci. 2000;320:81–4.PubMedCrossRef Cannata-Andia JB. Adynamic bone and chronic renal failure: an overview. Am J Med Sci. 2000;320:81–4.PubMedCrossRef
25.
Zurück zum Zitat Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000;102:2636–42.PubMedCrossRef Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation. 2000;102:2636–42.PubMedCrossRef
26.
Zurück zum Zitat Lencel P, Delplace S, Pilet P, Leterme D, Miellot F, Sourice S, et al. Cell-specific effects of TNF-alpha and IL-1beta on alkaline phosphatase. Implication for syndesmophyte formation and vascular calcification. Lab Invest. 2011;91(10):1434–42.PubMedCrossRef Lencel P, Delplace S, Pilet P, Leterme D, Miellot F, Sourice S, et al. Cell-specific effects of TNF-alpha and IL-1beta on alkaline phosphatase. Implication for syndesmophyte formation and vascular calcification. Lab Invest. 2011;91(10):1434–42.PubMedCrossRef
27.
Zurück zum Zitat Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–911.PubMedCrossRef Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–911.PubMedCrossRef
28.
Zurück zum Zitat Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, et al. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol. 2001;12:1927–36.PubMed Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, et al. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol. 2001;12:1927–36.PubMed
29.
Zurück zum Zitat Ikee R, Honda K, Oka M, Maesato K, Mano T, Moriya H, et al. Association of heart valve calcification with malnutrition–inflammation complex syndrome, beta-microglobulin, and carotid intima media thickness in patients on hemodialysis. Ther Apher Dial. 2008;12:464–8.PubMedCrossRef Ikee R, Honda K, Oka M, Maesato K, Mano T, Moriya H, et al. Association of heart valve calcification with malnutrition–inflammation complex syndrome, beta-microglobulin, and carotid intima media thickness in patients on hemodialysis. Ther Apher Dial. 2008;12:464–8.PubMedCrossRef
30.
Zurück zum Zitat Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–32.PubMedCrossRef Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–32.PubMedCrossRef
31.
Zurück zum Zitat Moe SM, O’Neill KD, Fineberg N, Persohn S, Ahmed S, Garrett P, et al. Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transpl. 2003;18:1152–8.CrossRef Moe SM, O’Neill KD, Fineberg N, Persohn S, Ahmed S, Garrett P, et al. Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transpl. 2003;18:1152–8.CrossRef
32.
Zurück zum Zitat Ogawa T, Ishida H, Akamatsu M, Matsuda N, Fujiu A, Ito K, et al. Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients. Int Urol Nephrol. 2010;42:187–94.PubMedCrossRef Ogawa T, Ishida H, Akamatsu M, Matsuda N, Fujiu A, Ito K, et al. Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients. Int Urol Nephrol. 2010;42:187–94.PubMedCrossRef
33.
Zurück zum Zitat Noordzij M, Cranenburg EM, Engelsman LF, Hermans MM, Boeschoten EW, Brandenburg VM, et al. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transpl. 2011;26:1662–9.CrossRef Noordzij M, Cranenburg EM, Engelsman LF, Hermans MM, Boeschoten EW, Brandenburg VM, et al. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transpl. 2011;26:1662–9.CrossRef
Metadaten
Titel
Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in incident hemodialysis patients
verfasst von
Harin Rhee
Sang Heon Song
Ihm Soo Kwak
Soo Bong Lee
Dong Won Lee
Eun Young Seong
Il Young Kim
Publikationsdatum
01.06.2012
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 3/2012
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0577-z

Weitere Artikel der Ausgabe 3/2012

Clinical and Experimental Nephrology 3/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.